about
The Prevalence and Management of Systemic Amyloidosis in Western CountriesGuidelines on the Use of Therapeutic Apheresis in Clinical Practice-Evidence-Based Approach from the Writing Committee of the American Society for Apheresis: The Seventh Special Issue.Amyloid nephropathyNon-neuronal and neuronal BACE1 elevation in association with angiopathic and leptomeningeal β-amyloid deposition in the human brain.Electron tomography reveals the fibril structure and lipid interactions in amyloid deposits.Flow cytometry-based characterization of underlying clonal B and plasma cells in patients with light chain amyloidosis.Minimally invasive minor salivary gland biopsy for the diagnosis of amyloidosis in a rheumatology clinicOcular adnexal and orbital amyloidosis: a case series and literature review.Intensity-modulated radiotherapy for localized nasopharyngeal amyloidosis : Case report and literature review.Long-term follow-up of secondary amyloidosis patients treated with tumor necrosis factor inhibitor therapy: A STROBE-compliant observational study.Risk factors for AA amyloidosis in Germany.Congestive Heart Failure with Preserved Ejection Fraction in a Patient with Light Chain (AL) Amyloidosis and Multiple Myeloma.Transanal endoscopic microsurgery: the first attempt in treatment of rectal amyloidoma.Relation of gelsolin amyloidosis and periodontal health.Using Covalent Labeling and Mass Spectrometry To Study Protein Binding Sites of Amyloid Inhibiting Molecules.Localized Nasopharyngeal Amyloidosis: A Clinicopathologic Series of 7 Cases with a Literature Review.Primary localized tracheobronchial amyloidosis presenting with massive hemoptysis: a case report and literature review.Transbronchial biopsies safely diagnose amyloid lung disease.A man with macroglossia and hemorrhagic bulla.Covalent labeling-mass spectrometry with non-specific reagents for studying protein structure and interactionsAcquired factor VII deficiency causing severe bleeding disorder secondary to AL amyloidosis of the liverBone scintigraphy with99mtechnetium-hydroxymethylene diphosphonate allows early diagnosis of cardiac involvement in patients with transthyretin-derived systemic amyloidosis
P2860
Q26740436-426C9B52-C401-4299-B1A5-249D274A7BB6Q30276550-51DFC274-38AC-4929-9959-E22F3365EA59Q35227671-D41A34A6-A617-4AFC-8AE0-4484E0C841EDQ35595669-AC614F47-5A46-4A93-A720-71D85AE0A34AQ36007352-6668577A-7712-4D92-B805-37D3E3EE1E13Q37094919-B3041761-1D68-4BC1-A9F7-EEE36B2D0A05Q37636042-FE0E19EA-6552-41DE-835C-6F1D75A24AC6Q38607031-FA4DB47A-7FD6-4B87-A656-A6A22653AB85Q38864938-ECFF9F5B-0AB3-4F57-A7EA-2AD22C59A8E5Q40073378-C75151ED-05CD-4897-B751-3387E30D982AQ40183920-CC1B68C5-6B2E-4C29-A535-BA285F8BA899Q41072464-822817D1-92E5-4063-951A-DB9D5196D285Q41868066-CCF62E3A-7A1F-4EAE-8BAC-B88AAFFAF124Q46891268-F36FC9E2-0825-4D7F-9453-AF35B54E91D6Q47657947-2D6CEED9-AE3C-465D-94AE-910776941BC9Q48339787-05470646-7646-4B69-BA49-FF8208B4F8F3Q51644510-9BD6ECD3-0AA7-435B-BE6C-64C68BF1D428Q52882471-001EDC2E-4068-4571-BFCE-77E974EA6121Q55519107-91B8866E-D13C-467B-A181-555CA3CD4879Q57175988-6A10BABA-E396-46DE-8C20-C5708D9797C2Q57821660-8BB3CD45-C0E8-44F7-BB59-2BC9AA57A340Q58125069-13D05766-1B6C-4B5B-9E54-3217588CE9C5
P2860
description
2013 nî lūn-bûn
@nan
2013 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի մարտին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Amyloidosis: a clinical overview.
@ast
Amyloidosis: a clinical overview.
@en
Amyloidosis: a clinical overview.
@nl
type
label
Amyloidosis: a clinical overview.
@ast
Amyloidosis: a clinical overview.
@en
Amyloidosis: a clinical overview.
@nl
prefLabel
Amyloidosis: a clinical overview.
@ast
Amyloidosis: a clinical overview.
@en
Amyloidosis: a clinical overview.
@nl
P1476
Amyloidosis: a clinical overview
@en
P2093
Bouke P C Hazenberg
P304
P356
10.1016/J.RDC.2013.02.012
P577
2013-03-13T00:00:00Z